Department of Health and Social Care
Government invests in global partnership to treat gonorrhoea
The £3.5 million investment will help develop new treatments for gonorrhoea and make them available to low- and middle-income countries.
The investment is part of a continued partnership with the Global Antibiotic Research and Development Partnership (GARDP), a not-for-profit research and development organisation co-founded by the World Health Organization and the Drugs for Neglected Disease initiative in 2016.
- enable global access to treatment, including in low- and middle-income countries where the burden of antimicrobial resistance (AMR) is greatest
- fund GARDP’s development of oral antibiotic zoliflodacin, which is now in the last stage of clinical trials before reaching the market
Zoliflodacin is one of the few antibiotics in development to specifically treat gonorrhoea and is significant as treatments for gonorrhoea are becoming less effective.
There have been cases of gonorrhoea developing resistance to recommended treatments, including in the UK.
Gonorrhoea is among the most common sexually-transmitted infections (STIs), with an estimated 87 million new cases globally every year.
The STI can have severe consequences on public health and, when left untreated, serious consequences for reproductive health as well as increased risk of transmission of HIV and other STIs.
Women, and marginalised and vulnerable groups are disproportionately affected.
Gonorrhoea has been identified as posing a significant threat to global health by the World Health Organization (WHO). There is now an urgent need for new treatment options, particularly for people in developing countries.
Addressing drug-resistant infections is critical to achieving the UN’s sustainable development goals, particularly the target for good health and wellbeing for all.
GARDP will now start pharmaceutical development activities for zoliflodacin, and will develop a new strategy for access and appropriate use in low- and middle-income countries that have a high number of cases of gonorrhoea.
Minister for Innovation, Nicola Blackwood, yesterday said:
The UK is a global leader in tackling antimicrobial resistance, a threat that is posing serious risks to health and the global economy, as well as killing hundreds of thousands of people around the world each year.
It is vital to fund new antibiotic research and development to tackle AMR and this innovative project will develop solutions to treat the global rise of gonorrhoea and improve the quality of people’s lives.
Dr Manica Balasegaram, Executive Director of GARDP, yesterday said:
We are excited to unveil our new strategy, 5 BY 25, outlining GARDP’s ambition to accelerate the development of 5 new treatments by 2025.
The recent initiation of the phase 3 trial of zoliflodacin is an important milestone towards bringing one of our 5 treatments a step closer to patients by 2025.
The global nature of the trial, across 4 continents, represents our commitment to ensuring this treatment is available to anyone in need, wherever they live.
Latest News from
Department of Health and Social Care
New recruitment drive to help 10,000 people with serious mental illness30/09/2020 10:10:10
£27 million has been announced for mental health charity Think Ahead to expand their mental health social work graduate programme.
Indoor inter-household mixing restricted in parts of the North East29/09/2020 16:10:00
Measures will be brought into law restricting inter-household mixing in indoor settings, including pubs and restaurants, in Durham, Gateshead, Newcastle, North Tyneside, South Tyneside, Northumberland and Sunderland.
NHS COVID-19 app: emails and SMS messages29/09/2020 12:10:00
The government is texting and emailing people across England to inform them of the new contact tracing app, available to download from the App Store and Google Play.
Landmark strategy launched to cement UK’s position as global leader in genomics28/09/2020 16:05:00
Health and Social Care Secretary Matt Hancock has heralded the launch of a landmark new strategy that will secure the UK’s future position as a global leader in genomics.
Huge increase in UK personal protective equipment production28/09/2020 15:05:00
Robust and resilient PPE supply chains will provide continuous flow to frontline.
NHS COVID-19 app has been downloaded over 10 million times28/09/2020 13:05:00
Over 10 million people in England and Wales have downloaded the app, 6 million on the first day.
New legal duty to self-isolate comes into force today28/09/2020 12:05:00
From today, people in England will be required by law to self-isolate if they test positive or are contacted by NHS Test and Trace.
More than 1 in 10 people in England have now been tested for coronavirus25/09/2020 16:10:00
NHS Test and Trace has now reached almost half a million people, including those testing positive and their contacts, to slow the transmission of coronavirus in England.
UK Government local coronavirus testing site opens in Aberdeen25/09/2020 14:43:00
A new UK Government funded walk-through coronavirus testing facility opened yesterday in the University of Aberdeen’s Roy Strathdee building.